Health Warning: Glass Particles Found in Vitamins Spark Massive Recall!
- Replies 0
In a startling revelation that underscores the importance of stringent quality control in pharmaceutical manufacturing, a recent recall has raised alarms for patients and healthcare providers alike.
The U.S. Food and Drug Administration (FDA) has announced a voluntary recall of injectable vitamins by the manufacturer. Find out the details of this recall and check your medicine cabinets now!
The recall involves one lot of Ascorbic Acid Solution for Injection, a vitamin C product produced by Nebraska-based STASKA Pharmaceuticals.
The affected lot, identified by the code SP2400058 with an expiration date of December 31, 2024, was found to contain glass particulates in some vials.
This discovery has prompted immediate action to ensure patient safety.
The FDA has emphasized that administering an injectable product contaminated with particulate matter could result in local irritation or swelling at the injection site. More alarmingly, if these particles travel through the bloodstream, they could block blood vessels, potentially leading to life-threatening complications such as stroke or even death.
The recalled product was distributed nationwide to licensed healthcare providers from July 31 to August 27, 2024.
While no adverse reactions or illnesses have been reported to date, the risk posed by the contaminated vials is significant enough to warrant a complete halt in their use.
STASKA Pharmaceuticals has taken a proactive stance in addressing the issue, reaching out to customers via email and phone to facilitate the return and replacement of the recalled products.
Healthcare providers in possession of the recalled lot are advised to cease use immediately, quarantine the product, and contact STASKA Pharmaceuticals for further instructions.
If you have concerns about the recall or have experienced any issues that may be related to the use of this injectable vitamin C product, it is recommended that you reach out to STASKA Pharmaceuticals at 402-782-2207 or 888-801-1370 during their business hours, Monday through Friday from 8 a.m. to 5 p.m. CT.
Additionally, contacting your physician or healthcare provider is a prudent step to ensure your health and safety.
This recall is not an isolated incident. In September, batches of the antiviral drug Veklury (remdesivir), used in the treatment of COVID-19, were recalled for similar reasons.
Earlier in the year, Methocarbamol, a drug used to treat muscle pain and stiffness, was also recalled due to the presence of white particles in the vials.
Remember, your health is your most valuable asset. Stay informed, stay vigilant, and don't hesitate to take action when your well-being is at stake.
Have you or someone you know been affected by a drug recall? How do you stay informed about the safety of your medications? Share your insights and experiences in the comments below.
The U.S. Food and Drug Administration (FDA) has announced a voluntary recall of injectable vitamins by the manufacturer. Find out the details of this recall and check your medicine cabinets now!
The recall involves one lot of Ascorbic Acid Solution for Injection, a vitamin C product produced by Nebraska-based STASKA Pharmaceuticals.
The affected lot, identified by the code SP2400058 with an expiration date of December 31, 2024, was found to contain glass particulates in some vials.
This discovery has prompted immediate action to ensure patient safety.
Injectable vitamins have been recalled by STASKA Pharmaceuticals due to potential glass contamination in one batch. Image source: Pexels.
The FDA has emphasized that administering an injectable product contaminated with particulate matter could result in local irritation or swelling at the injection site. More alarmingly, if these particles travel through the bloodstream, they could block blood vessels, potentially leading to life-threatening complications such as stroke or even death.
The recalled product was distributed nationwide to licensed healthcare providers from July 31 to August 27, 2024.
While no adverse reactions or illnesses have been reported to date, the risk posed by the contaminated vials is significant enough to warrant a complete halt in their use.
STASKA Pharmaceuticals has taken a proactive stance in addressing the issue, reaching out to customers via email and phone to facilitate the return and replacement of the recalled products.
Healthcare providers in possession of the recalled lot are advised to cease use immediately, quarantine the product, and contact STASKA Pharmaceuticals for further instructions.
If you have concerns about the recall or have experienced any issues that may be related to the use of this injectable vitamin C product, it is recommended that you reach out to STASKA Pharmaceuticals at 402-782-2207 or 888-801-1370 during their business hours, Monday through Friday from 8 a.m. to 5 p.m. CT.
Additionally, contacting your physician or healthcare provider is a prudent step to ensure your health and safety.
This recall is not an isolated incident. In September, batches of the antiviral drug Veklury (remdesivir), used in the treatment of COVID-19, were recalled for similar reasons.
Earlier in the year, Methocarbamol, a drug used to treat muscle pain and stiffness, was also recalled due to the presence of white particles in the vials.
Remember, your health is your most valuable asset. Stay informed, stay vigilant, and don't hesitate to take action when your well-being is at stake.
